跳至主要内容
临床试验/NCT02546128
NCT02546128Unknown不适用

LEICSTES = LEICeSter Tendon Extracorporeal Shockwave Studies Assessing the Benefits of the Addition of Extra-Corporeal Shockwave Treatment to a Structured Home-rehabilitation Programme for Patients With Tendinopathy.

University Hospitals, Leicester1 个研究点 分布在 1 个国家目标入组 720 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
720
试验地点
1
主要终点
improvement in pain as assessed by a 0-10 visual analogue scale (VAS)

研究概览

简要总结

To assess whether the addition of Extra-corporeal Shockwave Therapy (ESWT) to a structured home-exercise programme has any additional benefit to patients with tendinopathies

详细描述

This involves patients with one of 6 different defined chronic tendinopathies. These individual sites are run as discrete sub-studies, with randomisation n occurring within sub-study grouping

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients age >18
  • Symptoms (typically pain / stiffness) of at least 12 weeks of one of the following sites / conditions:
  • Plantar fasciitis
  • Insertional Achilles tendinopathy
  • Mid-substance Achilles tendinopathy
  • Patella tendinopathy
  • Trochanteric pain syndrome (gluteus medius insertional tendinopathy / trochanteric bursitis)
  • Tennis elbow
  • Referred for ESWT (shockwave) within the Sports Medicine Department
  • Objective imaging of tendon / structure confirming diagnosis and excluding tear or other structural injury (US or MRI acceptable)

排除标准

  • Patients with the normal exclusions for ESWT - including pre-existing skin injury over tendon site, recent steroid injection (within 6 weeks of ESWT starting), patients on anticoagulation, patients with haemophilia or other bleeding tendency, patients with current febrile illness
  • Previous ESWT treatment for the same condition

结局指标

主要结局

improvement in pain as assessed by a 0-10 visual analogue scale (VAS)

时间窗: primary outcome 3 months

次要结局

  • improvement in pain as assessed by a 0-10 visual analogue scale (VAS)(secondary outcome at 6 months post treatment)
  • improvement in function as assessed by several validated patient-rated outcome measures(3 months and 6 months)

研究者

发起方
University Hospitals, Leicester
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验